Monoclonal Antibodies
The immune system in our body produces antibodies to fight against cancerous cells. Therefore, your doctor would prescribe monoclonal antibodies to deal with relapsed multiple myeloma. Two common options that are officially approved by the FDA include Elotuzumab and Daratumumab. They are able to target proteins around the surface of cancerous cells. In general, these drugs can be infused into your vein. Consult your doctor carefully before starting because there might be many side effects, such as dizziness, throat tightness, coughing, wheezing, and trouble breathing. [9]
